Stock fact sheet · data as of

GMR Solutions Inc. (GMRS): fair value, margin of safety and Wheel Score

Healthcare · Medical - Care Facilities · United States · Speculative / Distressed

Close10.39
GLS fair value26.598 of 9 models
Margin of safety+61%price below fair value
Wheel Score38No optionscapped: no options
Health0/9Piotroski F-score
Moat1.5/10GLS 10-year score
Market cap$561M362k shares a day
Implied vol.-no listed options
P/E7.2EPS 1.44
Dividend yieldnone
Beta0.03moves less than the market
Next earnings9 Nov 2026in 24 days (after the close)

Is GMRS undervalued?

GMR Solutions Inc. (GMRS) closed at 10.39 on 16 Oct 2026. The GLS average fair value - the simple average of the 8 valuation models that produced a positive number - is 26.59, which puts the price 61% below it. 7 of the 8 models value the shares above the current price. A gap this wide is rare in our universe of ~7,400 US stocks and is exactly what the Value part of the Wheel Score rewards; it is also where the question "why is it this cheap?" matters most.

There is a wide gap between GLS Growth (1.84) and 10 Cap (47.77). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.

The nightly engine files GMRS under Speculative / Distressed - negative earnings or a Piotroski score of 3 or less - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.

Nine valuation models for GMRS

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF47.47+357%Present value of the projected free cash flows, discounted at the cost of capital
Graham Number21.79+110%The most a defensive investor pays for the earnings and book value per share
Graham Growth41.63+301%Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields
Lynch15.15+46%EPS × the earnings growth rate (PEG of 1), growth capped at 25%
GLS Growth1.84-82%EPS compounded ten years at the blended growth rate, discounted back at 15% a year
10 Cap47.77+360%Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%
Payback Time21.03+102%Eight years of compounded free cash flow: the price at which the business pays for itself
DDM--Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight
EPV16.05+55%Earnings power value: current EPS capitalised at 9% with no growth
Zombie (liquidation)-95.25-1017%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target19.67+89%Analysts' average 12-month price target. Not in the average

Quality and financial health

GMR Solutions Inc. scores only 0 of 9 on the Piotroski F-score, which fails the Sunday Scan's "6 or more" rule. A reading this low means several of the basic tests - positive earnings, positive operating cash flow, falling debt, no new share issuance - are not met. A GLS Moat score of 1.5/10 is a weak reading: the ten-year history the score grades (revenue, EPS, book value, margins, cash flow, share count, ROIC) has not been steady, so the Moat part of the Wheel Score contributes little.

Returns on capital are thin or negative - ROIC 3.7%, ROE 101.0%, ROA 2.8% - with debt at 26.31 times equity and a free-cash-flow yield of 11.5%. Debt of 26.31 times equity is on the high side for the sector and is worth checking against the cash flow before treating the stock as a long-term hold.

GMR Solutions Inc. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from Health Care, Patient Service 74%, Medicare 19%, Medicaid 6% (quarter Q2 FY2026).

Institutional ownership scores 10/10, insider activity 1/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score0 / 9ROIC3.7%
GLS Moat1.5 / 10ROE101.0%
Debt / equity26.31ROA2.8%
Free-cash-flow yield11.5%Payout ratio0%
Institutions10 / 10Insiders · Congress1 · 5 / 10

Wheel Score 38: No options

No options are listed on GMR Solutions Inc. in our nightly snapshot. The Wheel Score is therefore capped at 39 (it reads 38) and the stock is left out of every options screen; the fair value and health figures above are still useful for a plain stock position.

Volume runs at 362k shares a day on a market cap of $561M, with a beta of 0.03 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 10 of 20.

PartPointsFrom
Value25 / 2561% margin of safety
Health0 / 20Piotroski 0/9
Moat2 / 15moat 1.5/10
Premium0 / 20no option data
Stability10 / 20362k shares/day, $561M cap, beta 0.03

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

The next earnings report is due on 9 Nov 2026 (after the close), 24 days away; a 30-45-day put sold today would expire after it, which is worth weighing against the premium.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Medical - Care Facilities

The 12 companies below are the closest to GMR Solutions Inc. by market cap within the Medical - Care Facilities industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
STLN
Starling Oncology, Inc.
6.51--44Weak$651M
CYH
Community Health Systems, Inc.
2.99154.27+98%45Weak$422M
AUNA
Auna S.A.
5.3029.73+82%39No options$392M
SRTA
Strata Critical Medical, Inc.
4.2811.39+62%45Weak$379M
VMD
Viemed Healthcare, Inc.
9.6914.75+34%77Good$369M
AONC
American Oncology Network, Inc.
11.00--29No options$322M
INNV
Innovage Holding Corp.
8.988.21-9%45Weak$1.2B
USPH
U.S. Physical Therapy, Inc.
84.9150.56-68%45Weak$1.3B
NUTX
Nutex Health, Inc.
200.80732.07+73%39No options$1.4B
PNTG
The Pennant Group, Inc.
40.8226.64-53%51Fair$1.4B
HCSG
Healthcare Services Group, Inc.
21.4345.20+53%82Prime$1.5B
AGL
Agilon Health, Inc.
88.45--37Weak$1.5B

⚖ Compare GMRS with 7 of them   All Healthcare stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about GMRS

Is GMRS undervalued right now?

By the GLS models, yes: at 10.39 the stock is 61% below the average fair value of 26.59 (data as of 16 Oct 2026). Whether the discount is deserved is the question to research next.

What is the Wheel Score of GMRS and what does it mean?

GMRS has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".

What is the GLS fair value for GMRS?

26.59 per share as of 16 Oct 2026 - the simple average of the 8 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does GMR Solutions Inc. report earnings next?

The next earnings report is due on 9 Nov 2026 (after the close), 24 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.

Does GMRS have listed options, and how liquid are they?

No. The nightly options snapshot found no listed contracts on GMRS, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.